FDA Adverse Event Malfunction Summary report: N

60/60/90 MULTIPAK-OPTISTAR LE X50

MDR report key: 11132268 · Received January 7, 2021

Report

Report Number
3012395857-2020-00004
Event Type
Malfunction
Date Received
January 7, 2021
Report Date
December 4, 2020
Manufacturer
SHENZHEN BAOAN MEDICAL SUPPLIES CO., LTD
Product Code
DXT
PMA / PMN Number
K151960
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

OVERALL INVESTIGATION SUMMARY: INVESTIGATION HAS BEEN DONE AT BOON SITE. ISSUE REPORTED: THE FACILITY IS EXPERIENCING CONTRAST "WAS OUT"DURING MRA PROCEDURES. THE CONTRAST IS MIXING WITH THE SALINE PRIOR TO THE INJECTION. BOON HAS RECEIVED 4 COMPLAINTS FOR TUBING- CHECK VALVE ISSUES SINCE (B)(6) 2019 ACCOUNTING FOR (B)(4) OF THE TOTAL CUSTOMER COMPLAINTS. ROOT / PROBABLE CAUSE CODE. ROOT / PROBABLE CAUSE SUMMARY: THERE IS NO ROOT CAUSE, THE PRODUCT IS WORKING ACCORDING TO BOON SPECIFICATIONS AND CUSTOMER SPECIFICATIONS. THIS IS NOT A QUALITY ISSUE. DISPOSITION SUMMARY: WE SUGGEST THAT THE CUSTOMER CHANGES THE Y-TUBING TO CONTAIN 2 CHECK VALVES AS OPPOSED TO ONLY ONE. NO ACTION PLAN WILL BE TAKEN.

Description of Event or Problem · 1

THE INCIDENTS WERE REPORTED BY A FACILITY IN (B)(4) ON (B)(6) 2020. REPORTER STATES THAT THIS SITE RECENTLY SWITCHED FROM MR DUAL SYRINGE PACK # 801800 TO 801800B AND THEY ARE NOW EXPERIENCING WASH OUT AFTER ALL THEIR MRA EXAMS. THE SITE BELIEVES WITH THE NEW SYRINGE PACK THAT SOMEHOW THE CONTRAST AND SALINE ARE MIXING PRIOR TO THE INJECTION. THEY BELIEVE WITH THE HIGHER FLOW RATES THE CONTRAST IS BEING PUSHED INTO THE SALINE SYRINGE CAUSING DILUTED CONTRAST IMAGING. THIS HAS OCCURRED IN APPROX 8 EXAMS. THE PATIENTS ARE CONNECTED WHEN THE ISSUES OCCUR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
25524 60/60/90 MULTIPAK-OPTISTAR LE X50 60/60/90 MULTIPAK-OPTISTAR LE X50 DXT SHENZHEN BAOAN MEDICAL SUPPLIES CO., LTD 801800B

Patients

Seq Age Sex Outcome Treatment
1